Cargando…
Epithelial-mesenchymal transition: a hallmark in pancreatic cancer stem cell migration, metastasis formation, and drug resistance
Metastasis, tumor progression, and chemoresistance are the major causes of death in patients with pancreatic ductal adenocarcinoma (PDAC). Tumor dissemination is associated with the activation of an epithelial-to-mesenchymal transition (EMT) process, a program by which epithelial cells lose their ce...
Autor principal: | Safa, Ahmad R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623975/ https://www.ncbi.nlm.nih.gov/pubmed/34841087 http://dx.doi.org/10.20517/2394-4722.2020.55 |
Ejemplares similares
-
Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
por: Masuda, Tomonori, et al.
Publicado: (2023) -
Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012) -
Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition
por: Duran, George E, et al.
Publicado: (2017) -
Hallmarks of epithelial to mesenchymal transition are detectable in Crohn’s disease associated intestinal fibrosis
por: Scharl, Michael, et al.
Publicado: (2015) -
Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition
por: Russell, Ronan, et al.
Publicado: (2015)